Patents by Inventor Jay C Strum

Jay C Strum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CDK Inhibitors
    Publication number: 20150031880
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Application
    Filed: August 5, 2014
    Publication date: January 29, 2015
    Inventors: Francis X. Tavares, Jay C. Strum
  • CDK inhibitors
    Patent number: 8829012
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: September 9, 2014
    Assignee: G1 Therapeutics, Inc.
    Inventors: Francis X. Tavares, Jay C. Strum
  • CDK inhibitors
    Patent number: 8822683
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: September 2, 2014
    Assignee: G1 Therapeutics, Inc.
    Inventors: Francis X. Tavares, Jay C. Strum
  • CDK Inhibitors
    Publication number: 20140142306
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Application
    Filed: January 23, 2014
    Publication date: May 22, 2014
    Applicant: G1 Therapeutics, Inc.
    Inventors: Francis X. Tavares, Jay C. Strum
  • CDK Inhibitors
    Publication number: 20140142299
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Application
    Filed: January 23, 2014
    Publication date: May 22, 2014
    Applicant: G1 Therapeutics, Inc.
    Inventors: Francis X. Tavares, Jay C. Strum
  • CDK inhibitors
    Patent number: 8691830
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: April 8, 2014
    Assignee: G1 Therapeutics, Inc.
    Inventors: Francis X. Tavares, Jay C. Strum
  • CDK inhibitors
    Patent number: 8598197
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: December 3, 2013
    Assignee: G1 Therapeutics, Inc.
    Inventors: Francis X. Tavares, Jay C. Strum
  • CDK inhibitors
    Patent number: 8598186
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Grant
    Filed: April 24, 2013
    Date of Patent: December 3, 2013
    Assignee: G1 Therapeutics, Inc.
    Inventors: Francis X. Tavares, Jay C. Strum
  • CDK INHIBITORS
    Publication number: 20130237534
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Application
    Filed: April 24, 2013
    Publication date: September 12, 2013
    Applicant: G1 Therapeutics, Inc.
    Inventors: Francis X. Tavares, Jay C. Strum
  • CDK INHIBITORS
    Publication number: 20130237544
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Application
    Filed: April 24, 2013
    Publication date: September 12, 2013
    Applicant: G1 THERAPEUTICS, INC.
    Inventors: Francis X. Tavares, Jay C. Strum
  • CDK Inhibitors
    Publication number: 20130237533
    Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
    Type: Application
    Filed: April 24, 2013
    Publication date: September 12, 2013
    Applicant: G1 Therapeutics, Inc.
    Inventors: Francis X. Tavares, Jay C. Strum
  • HEMATOPOIETIC PROTECTION AGAINST CHEMOTHERAPEUTIC COMPOUNDS USING SELECTIVE CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS
    Publication number: 20110224227
    Abstract: Methods for reducing or preventing the effects of cytotoxic compounds in healthy cells are provided. The methods relate to the use of selective cyclin-dependent kinase (CDK) 4/6 inhibitors to induce transient quiescence in CDK4/6 dependent cells, such as hematopoietic stem cells and/or hematopoietic progenitor cells. Also described is a method of selecting compounds for reducing or preventing the effects of cytotoxic agents compounds in healthy cells.
    Type: Application
    Filed: October 1, 2009
    Publication date: September 15, 2011
    Inventors: Norman E. Sharpless, Jay C. Strum, John E. Bisi, Patrick J. Roberts, Matthew R. Ramsey
  • Novel compounds
    Publication number: 20040091969
    Abstract: Polypeptides and polynucleotides of the genes set forth in Table I and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing polypeptides and polynucleotides of the genes set forth in Table I in diagnostic assays.
    Type: Application
    Filed: November 12, 2003
    Publication date: May 13, 2004
    Inventors: Pankaj Agarwal, Marian Birkeland, John P Cogswell, Karen S Kabnick, Ying-Ta Lai, Safia K Rivzi, Shelby A Martensen, Randall F Smith, Jay C Strum, Qing Xie
  • Novel compounds
    Publication number: 20040092713
    Abstract: Polypeptides and polynucleotides of the genes set forth in Table I and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing polypeptides and polynucleoties of the genes set forth in Table I in diagnostic assays.
    Type: Application
    Filed: August 19, 2003
    Publication date: May 13, 2004
    Inventors: Pankaj Agarwal, John P Cogswell, Ying-Ta Lai, Shelby A Martesen, Safia K Rizvi, Randall F Smith, Jay C Strum, Zhaoying Xiang, Qing Xie
  • Novel compounds
    Publication number: 20030219862
    Abstract: Polypeptides and polynucleotides of the genes set forth in Table I and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing polypeptides and polynucleotides of the genes set forth in Table I in diagnostic assays.
    Type: Application
    Filed: April 28, 2003
    Publication date: November 27, 2003
    Inventors: Pankaj Agarwal, John P Cogswell, Karen S Kabnick, Ying-Ta Lai, Shelley A Martensen, Paul R Murdock, Safia K Rizvi, Randall F Smith, Jay C Strum, Zhaoying Xiang, Qing Xie